Updated Jul 16, 2026
Kazam Joshua A has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-23 | ALLO | Allogene Therapeutics, Inc. | M — Option exercise | 47.7K | $0.00 | |
| 2025-06-20 | KRON | Kronos Bio, Inc. | J — Other acquisition / disposition | 94.5K | $0.57 | $54K |
Kazam Joshua A is a corporate insider — currently tracked as Director of Allogene Therapeutics, Inc. (ALLO). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Kazam Joshua A profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.